The first part of the ID-ALS study to identify genetic alterations in people with amyotrophic lateral sclerosis (ALS) was successfully completed by Ambulanzpartner on 30.10.2022. In the study
At the Neurowoche 2022 together with the congress of the German Society for Neurology (DGN) in Berlin, our first experiences with the use of algorithm-based care recommendations as decision
The recording of the course of the disease amyotrophic lateral sclerosis (ALS) with the help of the ALS Functional Scale (ALSFRS-R) is of great relevance for those affected themselves, the ALS
We are constantly developing the ALS app with innovative ideas and feedback from our users. The latest version of the ALS app with new functions is available for download free of charge from the
This year, Ambulanzpartner is further developing its supply management of medical aids. It is a good fit to welcome an experienced aid coordinator to our team. We are pleased to announce that